Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2006; 12(15): 2412-2416
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2412
Table 1 Characteristics of the patients
n (%)MeanMedian
Sex
Boys48 (81.4)
Girls11 (18.6)
Age6-1810.5 ± 3.2410
(yr)
Age of HBV infection1-143.7 ± 3.093
(yr)
Duration of HBV infection1-166.8 ± 3.096
(yr)
Completed previous IFN-α treatment
Yes51 (86.4)
No8 (13.6)
ALT activity before treatment20-664101 ± 96.376
(IU/L)
Inflammation activity score
Grade 124 (40.7)
Grade 233 (55.9)
Grade 32 (3.4)
Grade 40
Staging
Stage 07 (11.9)
Stage 137 (62.7)
Stage 212 (20.3)
Stage 32 (3.4)
Stage 41 (1.7)
Serum HBV DNA level200 - 200 000135 632 ± 81 018200 000
(copies/mL)
Lamivudnie dose (mg per kg1.3 - 4.13.0 ± 0.852.9
of body weight)